Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05480930
Other study ID # IRB202201220
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 27, 2022
Est. completion date June 2025

Study information

Verified date May 2023
Source University of Florida
Contact Molly B Klarman, MPH
Phone 509 4600-7486
Email mklarman@ufl.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Children in resource-limited settings who develop illness at night are often isolated from care, resulting in progression to an emergency. A telemedicine and medication delivery service (TMDS) is a viable healthcare delivery option to bridge the gap in nighttime care. This interrupted time series study (pre/post) will evaluate a digital clinical decision-support (dCDS) tool. The objective is to assess if the tool is associated with an improvement in guideline adherence by TMDS providers.


Description:

Acute respiratory infection and diarrheal disease are the two leading causes of pediatric death between 1 month and 5 years of age globally. These common problems have well-established low-cost treatments. However, these treatments are most effective when administered early which is difficult in resource-limited settings, especially at night. Based on five years of formative NIH-funded research, the team has built a Telemedicine and Medication Delivery Service (TMDS) in Haiti to improve nighttime access to care and treatment for children called MotoMeds. The strategic plan is to design, deploy and evaluate MotoMeds by conducting four clinical studies titled Improving Nighttime Access to Care and Treatment (INACT1/2/3/4) in Haiti. INACT1-H was a needs assessment (2018-2019), INACT2-H was a pre-pilot deployment of MotoMeds that compared the congruence of clinical assessments at the call-center to in-person household assessments by providers (2019-2020), and INACT3-H was a pilot of a scalable model of MotoMeds that had provider assessment only at the call-center for most non-severe cases and had provider assessment at both the call-center and household for some non-severe/ moderate cases. In addition, the central call center serviced a geographically distant delivery zone, demonstrating proof of concept for a fully scaled model. INACT4-H will evaluate a digital clinical decision support (dCDS) tool designed for use at a pediatric TMDS in an interrupted time series study. The pre-intervention is use of the existing paper CDS tool and the intervention is use of the dCDS tool. This initiative is significant because it uses telemedicine and medication delivery to address one of the most fundamental challenges in pediatrics early access to pediatric healthcare.


Recruitment information / eligibility

Status Recruiting
Enrollment 2660
Est. completion date June 2025
Est. primary completion date May 2025
Accepts healthy volunteers No
Gender All
Age group N/A to 10 Years
Eligibility Inclusion criteria for child, parent/guardian participants: - Children 10 years of age or younger with an acute illness - Parent/guardian contacts the TMDS in regards to the illness during hours of operation - Parental/guardian agreement to a waiver of documentation of consent when contact is by phone only OR written consent/assent at the household from the parent/guardian and child (7yrs and older) for participants who receive a household visit. Exclusion criteria for child, parent/guardian participants: - No consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
paper-based clinical decision support (dCDS) tool
The paper based clinical decision support tools currently employed at the TMDS that are used to triage, assess and generate treatment plans for pediatric patients.
digital clinical decision support (dCDS) tool
The intervention is a digitized version of the paper based clinical decision support tools currently employed at the TMDS that are used to triage, assess and generate treatment plans for pediatric patients.

Locations

Country Name City State
Haiti CV Foundation Gressier Ouest

Sponsors (1)

Lead Sponsor Collaborator
University of Florida

Country where clinical trial is conducted

Haiti, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in provider guideline adherence rates at the household between use of the paper and digital clinical decision support tools (CDS). We will evaluate the change in rates of provider guideline adherence at the household between the 16 month period (minus 2 week wash out) where the existing paper CDS tools are used and the 16 month period (minus 2 week wash out) where the new digital CDS tools are used. Guideline adherence will be measured using the following features of the assessment and plan; severity determination and danger signs, provider household visit determination, and antibiotic and zinc prescriptions. Two 16 month intervention periods less the 2 week wash out.
Other Qualitative feedback from TMDS providers Qualitative feedback from the provider perspective framed with respect to content, usability of the user-interface (e.g., haptic vs typed data entry, navigation), satisfaction and technical challenges (connectivity, malfunctions, inter-operability). Approximately 1 hour
Primary Change in provider guideline adherence rates at the call center between use of the paper and digital clinical decision support tools (CDS). We will evaluate the change in rates of provider guideline adherence at the call center between the 16 month period (minus 2 week wash out) where the existing paper CDS tools are used and the 16 month period (minus 2 week wash out) where the new digital CDS tools are used. Guideline adherence will be measured using the following features of the assessment and plan; severity determination and danger signs, provider household visit determination, and antibiotic and zinc prescriptions. Two 16 month intervention periods less the 2 week wash out.
Secondary Enumeration of clinical status of participants at 10-day follow up All families will receive a follow-up call at 10 days post initial call to MotoMeds. The family will be asked about the clinical status of the child with regards to the initial medical complaint (resolved, better, same, worse, died). 10 days
Secondary Change in call duration between use of the paper and digital clinical decision support tools (CDS). Call duration is defined as the time elapsed from once the provider starts consulting the patient (filling out the case report form or face sheet) until the provider finishes the assessment and has communicated the treatment plan to the caller (prior to the consent process). The mean call duration while using the paper CDS will be compared to the mean call duration while using the digital CDS tool. From time incoming call is answered until treatment plan has been explained (approximately 10 to 20 minutes).
Secondary Change in time to medication delivery between use of the paper and digital clinical decision support tools (CDS). Time to medication delivery is defined as the time from once the provider starts consulting the patient (filling out the case report form or face sheet) until the driver (or driver and provider) arrives at the patient's home for delivery. The mean time to delivery while using the paper CDS will be compared to the mean time to delivery while using the digital CDS tool. From time incoming call is answered until medication is delivered to the participant's home (approximately 45-120 minutes).
See also
  Status Clinical Trial Phase
Completed NCT03574480 - Smartphone Applications to Improve Lifestyles in Olders Over 65 Years N/A
Not yet recruiting NCT04070066 - Educational Strategy IN Exchange Transfusion N/A
Active, not recruiting NCT05043220 - Covid-19 Predictors: Safety of Gynecological Oncology Patients Undergoing Systemic Cancer Therapy N/A
Recruiting NCT04045054 - Home-based Transitional Telecare for Older Veterans N/A
Completed NCT04652674 - Impact of Postoperative Telemedicine Visit vs In-person Visit on Patient Satisfaction During the COVID-19 Pandemic N/A
Completed NCT03295474 - Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
Completed NCT02196428 - Medical Telemonitoring Plus Individual Teleconsultation in Elderly N/A
Completed NCT03025217 - Total Lifestyle Coaching Pilot Study (TLC) N/A
Completed NCT01820234 - Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event N/A
Recruiting NCT04392518 - Telerehabilitation in Proximal Muscle Weakness N/A
Completed NCT05147038 - The Impact of Tele-coaching on the Physical Activity Level N/A
Not yet recruiting NCT05897710 - Virtual World-Based Cardiac Rehabilitation N/A
Not yet recruiting NCT06466837 - Just-In-Time Adaptive Interventions for Diabetic Patients N/A
Not yet recruiting NCT04444297 - 3D Telemedicine During COVID-19: Non-clinical Validation N/A
Not yet recruiting NCT04513496 - Telemedicine in HIV Care in Buenos Aires
Completed NCT05895539 - Evaluating Treatment Continuation in Telehealth Patients Receiving an Automated Patient-Reported Outcome Tool N/A
Active, not recruiting NCT03474692 - Virta Health Registry
Recruiting NCT05046392 - mHealth Facilitated Intervention to Improve Medication Adherence Among Persons Living With HIV N/A
Recruiting NCT05231018 - A Study on a Digital Platform for COVID19+ Patients, Designed to Facilitate Communication and Mental-health Care During and After Hospitalization. N/A
Recruiting NCT05617560 - Hospital@Home: Telemedical Care After Inpatient Hospital Stay N/A